- Home
- EFR vs CVRX Comparison
EFR vs CVRX Comparison
Compare EFR & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- CVRX
- Stock Information
- Founded
- EFR 2003
- CVRX 2000
- Country
- EFR United States
- CVRX United States
- Employees
- EFR N/A
- CVRX N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EFR Finance
- CVRX Health Care
- Exchange
- EFR Nasdaq
- CVRX Nasdaq
- Market Cap
- EFR 372.9M
- CVRX 337.5M
- IPO Year
- EFR N/A
- CVRX 2021
- Fundamental
- Price
- EFR $12.90
- CVRX $14.77
- Analyst Decision
- EFR
- CVRX Buy
- Analyst Count
- EFR 0
- CVRX 7
- Target Price
- EFR N/A
- CVRX $15.83
- AVG Volume (30 Days)
- EFR 88.6K
- CVRX 414.4K
- Earning Date
- EFR 01-01-0001
- CVRX 10-29-2024
- Dividend Yield
- EFR 9.43%
- CVRX N/A
- EPS Growth
- EFR N/A
- CVRX N/A
- EPS
- EFR 1.69
- CVRX N/A
- Revenue
- EFR N/A
- CVRX $47,255,000.00
- Revenue This Year
- EFR N/A
- CVRX $31.78
- Revenue Next Year
- EFR N/A
- CVRX $26.70
- P/E Ratio
- EFR $7.74
- CVRX N/A
- Revenue Growth
- EFR N/A
- CVRX 34.38
- 52 Week Low
- EFR $10.95
- CVRX $6.40
- 52 Week High
- EFR $13.29
- CVRX $33.14
- Technical
- Relative Strength Index (RSI)
- EFR 54.42
- CVRX 64.64
- Support Level
- EFR $12.80
- CVRX $13.03
- Resistance Level
- EFR $13.01
- CVRX $15.95
- Average True Range (ATR)
- EFR 0.09
- CVRX 0.86
- MACD
- EFR 0.01
- CVRX -0.26
- Stochastic Oscillator
- EFR 64.52
- CVRX 59.59
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of health care, industrial equipment, lodging and casinos, oil and gas, publishing, radio and television, telecommunications, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.